Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	high voltage-gated calcium channel activity	CACNA1A CACNA1B CACNA1E CACNA1F CACNA1H	6.39e-09	14	103	5	GO:0008331
GeneOntologyMolecularFunction	voltage-gated calcium channel activity	CACNA1A CACNA1B CACNA1E CACNA1F TMC2 CACNA1H	1.29e-07	46	103	6	GO:0005245
GeneOntologyMolecularFunction	calcium channel activity	CACNA1A CACNA1B CACNA1E CACNA1F TMC2 TPCN1 CACNA1H	4.72e-06	129	103	7	GO:0005262
GeneOntologyMolecularFunction	voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels	CACNA1A CACNA1B CACNA1E	1.09e-05	9	103	3	GO:0099511
GeneOntologyMolecularFunction	voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels	CACNA1A CACNA1B CACNA1E	1.09e-05	9	103	3	GO:0099626
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	CACNA1A CACNA1B CACNA1E CACNA1F TMC2 TPCN1 CACNA1H	1.33e-05	151	103	7	GO:0015085
GeneOntologyMolecularFunction	D-ribulose-phosphate 3-epimerase activity	RPEL1 RPE	2.64e-05	2	103	2	GO:0004750
GeneOntologyMolecularFunction	voltage-gated channel activity	CACNA1A CACNA1B CACNA1E CACNA1F TMC2 TPCN1 CACNA1H	4.73e-05	184	103	7	GO:0022832
GeneOntologyMolecularFunction	gated channel activity	CACNA1A CACNA1B CACNA1E CACNA1F TMC2 ANXA6 CHRNA1 TPCN1 CACNA1H	5.81e-05	334	103	9	GO:0022836
GeneOntologyMolecularFunction	monoatomic cation channel activity	CACNA1A CACNA1B CACNA1E CACNA1F TMC2 CHRNA1 TPCN1 SCN3A CACNA1H	7.13e-05	343	103	9	GO:0005261
GeneOntologyMolecularFunction	monoatomic ion channel activity	CACNA1A CACNA1B CACNA1E CACNA1F TMC2 ANXA6 CHRNA1 TPCN1 SCN3A CACNA1H	1.31e-04	459	103	10	GO:0005216
GeneOntologyMolecularFunction	voltage-gated monoatomic cation channel activity	CACNA1A CACNA1B CACNA1E CACNA1F TMC2 CACNA1H	1.37e-04	152	103	6	GO:0022843
GeneOntologyMolecularFunction	calmodulin binding	CACNA1A SPTAN1 RRAD ADCY1 ADCY3 SCN3A CAMSAP2	1.91e-04	230	103	7	GO:0005516
GeneOntologyMolecularFunction	calcium- and calmodulin-responsive adenylate cyclase activity	ADCY1 ADCY3	2.61e-04	5	103	2	GO:0008294
GeneOntologyMolecularFunction	voltage-gated sodium channel activity	TPCN1 SCN3A CACNA1H	3.18e-04	26	103	3	GO:0005248
GeneOntologyMolecularFunction	voltage-gated monoatomic ion channel activity	CACNA1A CACNA1B CACNA1E CACNA1F TMC2 CACNA1H	3.63e-04	182	103	6	GO:0005244
GeneOntologyMolecularFunction	channel activity	CACNA1A CACNA1B CACNA1E CACNA1F TMC2 ANXA6 CHRNA1 TPCN1 SCN3A CACNA1H	3.83e-04	525	103	10	GO:0015267
GeneOntologyMolecularFunction	passive transmembrane transporter activity	CACNA1A CACNA1B CACNA1E CACNA1F TMC2 ANXA6 CHRNA1 TPCN1 SCN3A CACNA1H	3.89e-04	526	103	10	GO:0022803
GeneOntologyMolecularFunction	microtubule motor activity	APPBP2 KIF3A KIF7 DNAH8	4.71e-04	70	103	4	GO:0003777
GeneOntologyMolecularFunction	spectrin binding	SPTAN1 KIF3A CAMSAP2	7.10e-04	34	103	3	GO:0030507
GeneOntologyMolecularFunction	carbohydrate binding	UAP1 SI MRC2 VCAN RPEL1 CRYBG1 RPE	1.13e-03	310	103	7	GO:0030246
GeneOntologyMolecularFunction	ATP-dependent activity	APPBP2 IPO8 ABCA13 ATP9B ATP9A KIF3A KIF7 MDN1 DNAH8 TOP2A	1.27e-03	614	103	10	GO:0140657
GeneOntologyMolecularFunction	racemase and epimerase activity, acting on carbohydrates and derivatives	RPEL1 RPE	1.41e-03	11	103	2	GO:0016857
GeneOntologyMolecularFunction	amyloid-beta binding	CACNA1A CACNA1B TLR2 VBP1	1.93e-03	102	103	4	GO:0001540
GeneOntologyMolecularFunction	sodium channel activity	TPCN1 SCN3A CACNA1H	2.45e-03	52	103	3	GO:0005272
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	CACNA1A CACNA1B CACNA1E CACNA1F TMC2 TPCN1 SCN3A CACNA1H	2.81e-03	465	103	8	GO:0046873
GeneOntologyMolecularFunction	cytoskeletal motor activity	APPBP2 KIF3A KIF7 DNAH8	3.27e-03	118	103	4	GO:0003774
GeneOntologyBiologicalProcess	calcium ion import across plasma membrane	CACNA1A CACNA1B CACNA1E CACNA1F CACNA1H	3.69e-06	48	101	5	GO:0098703
GeneOntologyBiologicalProcess	calcium ion import into cytosol	CACNA1A CACNA1B CACNA1E CACNA1F CACNA1H	3.69e-06	48	101	5	GO:1902656
GeneOntologyBiologicalProcess	transmission of nerve impulse	CACNA1A CACNA1E RAPGEF4 CHRNA1 SCN3A CACNA1H	1.87e-05	112	101	6	GO:0019226
GeneOntologyBiologicalProcess	exocytosis	CACNA1A CACNA1B CACNA1E RAPGEF4 PPFIA3 ATP9A WASHC5 CADPS GAB4 CACNA1H	5.35e-05	434	101	10	GO:0006887
GeneOntologyBiologicalProcess	regulated exocytosis	CACNA1A CACNA1B CACNA1E RAPGEF4 PPFIA3 CADPS GAB4 CACNA1H	9.26e-05	291	101	8	GO:0045055
GeneOntologyBiologicalProcess	regulation of vesicle-mediated transport	CACNA1A CACNA1B CACNA1E ABCA13 RAPGEF4 ATP9A KIF3A NOD2 CADPS TLR2 GAB4 CACNA1H	1.02e-04	667	101	12	GO:0060627
GeneOntologyBiologicalProcess	response to pain	CACNA1A CACNA1B CACNA1E SCN3A	1.13e-04	51	101	4	GO:0048265
GeneOntologyBiologicalProcess	calcium ion import	CACNA1A CACNA1B CACNA1E CACNA1F CACNA1H	1.21e-04	98	101	5	GO:0070509
GeneOntologyBiologicalProcess	regulation of exocytosis	CACNA1A CACNA1E RAPGEF4 ATP9A CADPS GAB4 CACNA1H	1.50e-04	233	101	7	GO:0017157
GeneOntologyCellularComponent	voltage-gated calcium channel complex	CACNA1A CACNA1B CACNA1E CACNA1F CACNA1H	2.93e-06	46	102	5	GO:0005891
GeneOntologyCellularComponent	calcium channel complex	CACNA1A CACNA1B CACNA1E CACNA1F CACNA1H	2.89e-05	73	102	5	GO:0034704
GeneOntologyCellularComponent	monoatomic ion channel complex	CACNA1A CACNA1B CACNA1E CACNA1F CHRNA1 TPCN1 SCN3A CACNA1H	5.31e-04	378	102	8	GO:0034702
GeneOntologyCellularComponent	cell body	CACNA1A CACNA1B CACNA1E CACNA1F RAPGEF4 GRM8 KIF3A WASHC5 SCN3A TLR2 SORCS2 CACNA1H USH2A	5.83e-04	929	102	13	GO:0044297
GeneOntologyCellularComponent	photoreceptor cell cilium	CACNA1F RAPGEF4 KIF3A VCAN USH2A	6.01e-04	139	102	5	GO:0097733
GeneOntologyCellularComponent	presynaptic active zone	CACNA1A CACNA1B PPFIA3 GRM8 CACNA1H	6.41e-04	141	102	5	GO:0048786
GeneOntologyCellularComponent	neuronal cell body	CACNA1A CACNA1B CACNA1E CACNA1F RAPGEF4 GRM8 KIF3A WASHC5 SCN3A SORCS2 CACNA1H USH2A	7.61e-04	835	102	12	GO:0043025
GeneOntologyCellularComponent	spectrin	SPTA1 SPTAN1	8.30e-04	9	102	2	GO:0008091
GeneOntologyCellularComponent	9+0 non-motile cilium	CACNA1F RAPGEF4 KIF3A VCAN USH2A	9.26e-04	153	102	5	GO:0097731
GeneOntologyCellularComponent	cation channel complex	CACNA1A CACNA1B CACNA1E CACNA1F SCN3A CACNA1H	1.04e-03	235	102	6	GO:0034703
GeneOntologyCellularComponent	perisynaptic extracellular matrix	TNC VCAN	1.26e-03	11	102	2	GO:0098966
GeneOntologyCellularComponent	presynapse	CACNA1A CACNA1B CACNA1E RAPGEF4 PPFIA3 GRM8 ADCY1 CADPS C1QC CACNA1H USH2A SENP5	1.27e-03	886	102	12	GO:0098793
GeneOntologyCellularComponent	cuticular plate	SPTA1 SPTAN1	1.78e-03	13	102	2	GO:0032437
GeneOntologyCellularComponent	synapse-associated extracellular matrix	TNC VCAN	1.78e-03	13	102	2	GO:0099535
GeneOntologyCellularComponent	glutamatergic synapse	CACNA1A CACNA1B SPTAN1 RAPGEF4 PPFIA3 GRM8 ADCY1 KIF3A CADPS C1QC CACNA1H	2.13e-03	817	102	11	GO:0098978
Domain	VDCCAlpha1	CACNA1A CACNA1B CACNA1E CACNA1F CACNA1H	1.14e-09	10	103	5	IPR002077
Domain	Channel_four-helix_dom	CACNA1A CACNA1B CACNA1E CACNA1F TPCN1 SCN3A CACNA1H	2.66e-08	57	103	7	IPR027359
Domain	-	CACNA1A CACNA1B CACNA1E CACNA1F TPCN1 SCN3A CACNA1H	2.66e-08	57	103	7	1.20.120.350
Domain	Ca_chan_IQ	CACNA1A CACNA1B CACNA1E CACNA1F	3.01e-08	7	103	4	SM01062
Domain	Ca_chan_IQ	CACNA1A CACNA1B CACNA1E CACNA1F	3.01e-08	7	103	4	PF08763
Domain	VDCC_a1su_IQ	CACNA1A CACNA1B CACNA1E CACNA1F	3.01e-08	7	103	4	IPR014873
Domain	GPHH	CACNA1A CACNA1B CACNA1E CACNA1F	3.01e-08	7	103	4	PF16905
Domain	GPHH_dom	CACNA1A CACNA1B CACNA1E CACNA1F	3.01e-08	7	103	4	IPR031649
Domain	FRG2	FRG2 FRG2C FRG2B	1.63e-07	3	103	3	PF15315
Domain	FRG2	FRG2 FRG2C FRG2B	1.63e-07	3	103	3	IPR026245
Domain	Ion_trans_dom	CACNA1A CACNA1B CACNA1E CACNA1F TPCN1 SCN3A CACNA1H	3.20e-06	114	103	7	IPR005821
Domain	Ion_trans	CACNA1A CACNA1B CACNA1E CACNA1F TPCN1 SCN3A CACNA1H	3.20e-06	114	103	7	PF00520
Domain	Ribul_P_3_epim	RPEL1 RPE	3.01e-05	2	103	2	PF00834
Domain	RIBUL_P_3_EPIMER_1	RPEL1 RPE	3.01e-05	2	103	2	PS01085
Domain	Ribul_P_3_epim	RPEL1 RPE	3.01e-05	2	103	2	IPR026019
Domain	Ribul_P_3_epim-like	RPEL1 RPE	3.01e-05	2	103	2	IPR000056
Domain	RibuloseP-bd_barrel	RPEL1 RPE	9.00e-05	3	103	2	IPR011060
Domain	EFhand_Ca_insen	SPTA1 SPTAN1	4.45e-04	6	103	2	PF08726
Domain	EF-hand_Ca_insen	SPTA1 SPTAN1	4.45e-04	6	103	2	IPR014837
Domain	AC_N	ADCY1 ADCY3	8.25e-04	8	103	2	IPR032628
Domain	Adcy	ADCY1 ADCY3	8.25e-04	8	103	2	IPR030672
Domain	P_TREFOIL_1	SI ZP1	8.25e-04	8	103	2	PS00025
Domain	AC_N	ADCY1 ADCY3	8.25e-04	8	103	2	PF16214
Domain	P_trefoil_CS	SI ZP1	8.25e-04	8	103	2	IPR017957
Domain	P_TREFOIL_2	SI ZP1	1.06e-03	9	103	2	PS51448
Domain	PD	SI ZP1	1.06e-03	9	103	2	SM00018
Domain	EF-hand-dom_pair	CACNA1B CACNA1F SPTA1 SPTAN1 CBLC TPCN1 SCN3A	1.06e-03	287	103	7	IPR011992
Domain	-	SI ZP1	1.60e-03	11	103	2	4.10.110.10
Domain	P_trefoil_dom	SI ZP1	1.92e-03	12	103	2	IPR000519
Domain	CYTOCHROME_B5_2	FADS2 HERC2	2.26e-03	13	103	2	PS50255
Domain	CYTOCHROME_B5_1	FADS2 HERC2	2.26e-03	13	103	2	PS00191
Domain	P_typ_ATPase_c	ATP9B ATP9A	2.62e-03	14	103	2	IPR032630
Domain	P-type_ATPase_N	ATP9B ATP9A	2.62e-03	14	103	2	IPR032631
Domain	ATPase_dyneun-rel_AAA	MDN1 DNAH8	2.62e-03	14	103	2	IPR011704
Domain	Cyt-b5	FADS2 HERC2	2.62e-03	14	103	2	PF00173
Domain	P-type_ATPase_IV	ATP9B ATP9A	2.62e-03	14	103	2	IPR006539
Domain	-	FADS2 HERC2	2.62e-03	14	103	2	3.10.120.10
Domain	Cyt_B5-like_heme/steroid-bd	FADS2 HERC2	2.62e-03	14	103	2	IPR001199
Domain	Cyt-b5	FADS2 HERC2	2.62e-03	14	103	2	SM01117
Domain	PhoLip_ATPase_C	ATP9B ATP9A	2.62e-03	14	103	2	PF16212
Domain	PhoLip_ATPase_N	ATP9B ATP9A	2.62e-03	14	103	2	PF16209
Domain	AAA_5	MDN1 DNAH8	2.62e-03	14	103	2	PF07728
Domain	Spectrin_alpha_SH3	SPTA1 SPTAN1	3.02e-03	15	103	2	IPR013315
Domain	A/G_cyclase_CS	ADCY1 ADCY3	3.88e-03	17	103	2	IPR018297
Domain	Aminotran_1_2	SPTLC1 KYAT1	3.88e-03	17	103	2	PF00155
Domain	Aminotransferase_I/II	SPTLC1 KYAT1	3.88e-03	17	103	2	IPR004839
Domain	-	ADCY1 ADCY3	4.35e-03	18	103	2	3.30.70.1230
Domain	Nucleotide_cyclase	ADCY1 ADCY3	4.35e-03	18	103	2	IPR029787
Domain	Guanylate_cyc	ADCY1 ADCY3	4.84e-03	19	103	2	PF00211
Domain	GUANYLATE_CYCLASE_2	ADCY1 ADCY3	4.84e-03	19	103	2	PS50125
Domain	A/G_cyclase	ADCY1 ADCY3	4.84e-03	19	103	2	IPR001054
Domain	GUANYLATE_CYCLASE_1	ADCY1 ADCY3	4.84e-03	19	103	2	PS00452
Domain	CYCc	ADCY1 ADCY3	4.84e-03	19	103	2	SM00044
Pathway	KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY	CACNA1A CACNA1B CACNA1E CACNA1F CACNA1H	1.42e-07	23	78	5	M47666
Pathway	KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL	CACNA1A CACNA1B CACNA1E CACNA1F CACNA1H	2.22e-07	25	78	5	M47948
Pathway	REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING	CACNA1A CACNA1B CACNA1E	2.60e-05	11	78	3	MM14498
Pathway	REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING	CACNA1A CACNA1B CACNA1E	2.60e-05	11	78	3	M26913
Pathway	KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY	CACNA1A CACNA1B CACNA1E	2.60e-05	11	78	3	M47958
Pathway	KEGG_CALCIUM_SIGNALING_PATHWAY	CACNA1A CACNA1B CACNA1E CACNA1F ADCY1 ADCY3 CACNA1H	5.65e-05	178	78	7	M2890
Pathway	WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS	CACNA1A CACNA1B CACNA1E ANXA6 ADCY1 ADCY3	1.61e-04	147	78	6	MM15854
Pathway	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	CACNA1A CACNA1B CACNA1E PPFIA3 ADCY1 ADCY3 CHRNA1	1.64e-04	211	78	7	MM14502
Pathway	WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS	CACNA1A CACNA1B CACNA1E ANXA6 ADCY1 ADCY3	1.86e-04	151	78	6	M39329
Pathway	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	CACNA1A CACNA1E RAPGEF4 ADCY1 ADCY3	3.26e-04	108	78	5	M17034
Pathway	KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY	CACNA1B CACNA1F	4.47e-04	6	78	2	M47762
Pathway	REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS	SPTA1 SPTAN1 SCN3A	6.55e-04	31	78	3	M877
Pathway	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	CACNA1A CACNA1B CACNA1E PPFIA3 ADCY1 ADCY3 CHRNA1	7.25e-04	270	78	7	M15514
Pubmed	International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels.	CACNA1A CACNA1B CACNA1E CACNA1F CACNA1H	2.84e-11	9	105	5	16382099
Pubmed	Evolutionary insights into T-type Ca2+ channel structure, function, and ion selectivity from the Trichoplax adhaerens homologue.	CACNA1B CACNA1E CACNA1F CACNA1H	5.44e-09	8	105	4	28330839
Pubmed	The intracellular C-terminus confers compartment-specific targeting of voltage-gated calcium channels.	CACNA1A CACNA1B CACNA1E	2.67e-08	3	105	3	38996073
Pubmed	Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics.	CACNA1A CACNA1B CACNA1E	2.67e-08	3	105	3	24523520
Pubmed	FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients.	FRG2 FRG2C FRG2B	2.67e-08	3	105	3	15520407
Pubmed	Voltage-activated calcium channel expression profiles in mouse brain and cultured hippocampal neurons.	CACNA1A CACNA1B CACNA1E CACNA1F	1.04e-07	15	105	4	20188150
Pubmed	Differential neuronal targeting of a new and two known calcium channel β4 subunit splice variants correlates with their regulation of gene expression.	CACNA1A CACNA1B CACNA1E CACNA1F	1.04e-07	15	105	4	24453333
Pubmed	Cerebellar granule cell signaling is indispensable for normal motor performance.	CACNA1A CACNA1B CACNA1E	1.07e-07	4	105	3	37141091
Pubmed	Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry.	CACNA1A CACNA1B CACNA1E	1.07e-07	4	105	3	32616470
Pubmed	Chromosomal localization of the human genes for alpha 1A, alpha 1B, and alpha 1E voltage-dependent Ca2+ channel subunits.	CACNA1A CACNA1B CACNA1E	2.66e-07	5	105	3	8825650
Pubmed	Functional disorders of the sympathetic nervous system in mice lacking the alpha 1B subunit (Cav 2.2) of N-type calcium channels.	CACNA1A CACNA1B CACNA1E	2.66e-07	5	105	3	11296258
Pubmed	Antinociceptive effect of different types of calcium channel inhibitors and the distribution of various calcium channel alpha 1 subunits in the dorsal horn of spinal cord in mice.	CACNA1A CACNA1B CACNA1E	2.66e-07	5	105	3	15451373
Pubmed	An action potential initiation mechanism in distal axons for the control of dopamine release.	CACNA1A CACNA1B CACNA1E	5.31e-07	6	105	3	35324301
Pubmed	Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis.	CACNA1A CACNA1B CACNA1E	5.31e-07	6	105	3	12827191
Pubmed	Direct interaction of gbetagamma with a C-terminal gbetagamma-binding domain of the Ca2+ channel alpha1 subunit is responsible for channel inhibition by G protein-coupled receptors.	CACNA1A CACNA1B CACNA1E	5.31e-07	6	105	3	9238069
Pubmed	Enhanced expression of L-type Cav1.3 calcium channels in murine embryonic hearts from Cav1.2-deficient mice.	CACNA1E CACNA1F CACNA1H	9.28e-07	7	105	3	12900400
Pubmed	Rebuilding essential active zone functions within a synapse.	CACNA1A CACNA1B CACNA1E	9.28e-07	7	105	3	35176221
Pubmed	Kif3a regulates planar polarization of auditory hair cells through both ciliary and non-ciliary mechanisms.	SPTA1 SPTAN1 KIF3A	9.28e-07	7	105	3	21752934
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	DCAF1 CACNA1E APPBP2 TNC ZNF559 SPTAN1 LIPF BCL2L2 XRCC1 RRAD MDN1 VCAN ZFP1 ZNF561 PARP9 NME4	1.69e-06	1293	105	16	15342556
Pubmed	Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development.	CACNA1A CACNA1B CACNA1E CACNA1F SCN3A CACNA1H	4.25e-06	139	105	6	16985003
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	CACNA1A CACNA1B CACNA1E CACNA1F	5.35e-06	38	105	4	30786075
Pubmed	Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis.	NOD2 IL23R	9.03e-06	2	105	2	17877509
Pubmed	NOD2/CARD15 and IL23R genetic variability in 204 Algerian Crohn's disease.	NOD2 IL23R	9.03e-06	2	105	2	24679666
Pubmed	NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.	NOD2 TLR2	9.03e-06	2	105	2	15214053
Pubmed	Involvement of tenascin-C and PG-M/versican in flexor tenosynovial pathology of idiopathic carpal tunnel syndrome.	TNC VCAN	9.03e-06	2	105	2	16493581
Pubmed	Blocking the R-type (Cav2.3) Ca2+ channel enhanced morphine analgesia and reduced morphine tolerance.	CACNA1B CACNA1E	9.03e-06	2	105	2	15610184
Pubmed	Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels.	CACNA1A CACNA1B	9.03e-06	2	105	2	23426690
Pubmed	Recognition of Borrelia burgdorferi by NOD2 is central for the induction of an inflammatory reaction.	NOD2 TLR2	9.03e-06	2	105	2	20441518
Pubmed	Common variants in NOD2 and IL23R are not associated with inflammatory bowel disease in Indians.	NOD2 IL23R	9.03e-06	2	105	2	21155887
Pubmed	Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children.	NOD2 IL23R	9.03e-06	2	105	2	19896081
Pubmed	Bacterial peptidoglycan breaks down intestinal tolerance via mast cell activation: the role of TLR2 and NOD2.	NOD2 TLR2	9.03e-06	2	105	2	17563761
Pubmed	Gender specific hippocampal whole genome transcriptome data from mice lacking the Cav2.3 R-type or Cav3.2 T-type voltage-gated calcium channel.	CACNA1E CACNA1H	9.03e-06	2	105	2	28393090
Pubmed	Synthetic Aβ oligomers (Aβ(1-42) globulomer) modulate presynaptic calcium currents: prevention of Aβ-induced synaptic deficits by calcium channel blockers.	CACNA1A CACNA1B	9.03e-06	2	105	2	23376566
Pubmed	A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.	NOD2 IL23R	9.03e-06	2	105	2	17068223
Pubmed	NOD2 and TLR2 ligands trigger the activation of basophils and eosinophils by interacting with dermal fibroblasts in atopic dermatitis-like skin inflammation.	NOD2 TLR2	9.03e-06	2	105	2	26388234
Pubmed	Butyrate mediates nucleotide-binding and oligomerisation domain (NOD) 2-dependent mucosal immune responses against peptidoglycan.	NOD2 TLR2	9.03e-06	2	105	2	19830732
Pubmed	NOD2/CARD15 genotype influences MDP-induced cytokine release and basal IL-12p40 levels in primary isolated peripheral blood monocytes.	NOD2 IL23R	9.03e-06	2	105	2	18383179
Pubmed	Invasive Streptococcus mutans induces inflammatory cytokine production in human aortic endothelial cells via regulation of intracellular toll-like receptor 2 and nucleotide-binding oligomerization domain 2.	NOD2 TLR2	9.03e-06	2	105	2	27004566
Pubmed	Nucleotide-binding oligomerization domain 2 and Toll-like receptor 2 function independently in a murine model of arthritis triggered by intraarticular peptidoglycan.	NOD2 TLR2	9.03e-06	2	105	2	20131263
Pubmed	CaV 2.1 α1 subunit motifs that control presynaptic CaV 2.1 subtype abundance are distinct from CaV 2.1 preference.	CACNA1A CACNA1B	9.03e-06	2	105	2	38155373
Pubmed	Signaling via pattern recognition receptors NOD2 and TLR2 contributes to immunomodulatory control of lethal pneumovirus infection.	NOD2 TLR2	9.03e-06	2	105	2	27312104
Pubmed	αII-spectrin regulates invadosome stability and extracellular matrix degradation.	SPTA1 SPTAN1	9.03e-06	2	105	2	25830635
Pubmed	Staphylococcal peptidoglycan co-localizes with Nod2 and TLR2 and activates innate immune response via both receptors in primary murine keratinocytes.	NOD2 TLR2	9.03e-06	2	105	2	20949035
Pubmed	Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status.	NOD2 IL23R	9.03e-06	2	105	2	18022867
Pubmed	Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation.	NOD2 IL23R	9.03e-06	2	105	2	20177049
Pubmed	Nod2 deficiency impairs inflammatory and epithelial aspects of the cutaneous wound-healing response.	NOD2 TLR2	9.03e-06	2	105	2	22951952
Pubmed	IL23R Arg381Gln is associated with childhood onset inflammatory bowel disease in Scotland.	NOD2 IL23R	9.03e-06	2	105	2	17337463
Pubmed	IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease.	NOD2 IL23R	9.03e-06	2	105	2	17484863
Pubmed	Non-Mendelian inheritance during inbreeding of Cav3.2 and Cav2.3 deficient mice.	CACNA1E CACNA1H	9.03e-06	2	105	2	33009476
Pubmed	Compensatory contribution of Cav2.3 channels to acetylcholine release at the neuromuscular junction of tottering mice.	CACNA1A CACNA1E	9.03e-06	2	105	2	16381801
Pubmed	Nod2 suppresses Borrelia burgdorferi mediated murine Lyme arthritis and carditis through the induction of tolerance.	NOD2 TLR2	9.03e-06	2	105	2	21387014
Pubmed	Two separate Ni(2+) -sensitive voltage-gated Ca(2+) channels modulate transretinal signalling in the isolated murine retina.	CACNA1E CACNA1H	9.03e-06	2	105	2	21883984
Pubmed	Association of NOD2 and IL23R with inflammatory bowel disease in Puerto Rico.	NOD2 IL23R	9.03e-06	2	105	2	25259511
Pubmed	Glioma-derived versican promotes tumor expansion via glioma-associated microglial/macrophages Toll-like receptor 2 signaling.	VCAN TLR2	9.03e-06	2	105	2	25452390
Pubmed	Aberrant Expression of Bacterial Pattern Recognition Receptor NOD2 of Basophils and Microbicidal Peptides in Atopic Dermatitis.	NOD2 TLR2	9.03e-06	2	105	2	27077833
Pubmed	The crosstalk between TLR2 and NOD2 in Aspergillus fumigatus keratitis.	NOD2 TLR2	9.03e-06	2	105	2	25549945
Pubmed	Toll-like receptor 2 and nucleotide-binding oligomerization domain-2 play divergent roles in the recognition of gut-derived lactobacilli and bifidobacteria in dendritic cells.	NOD2 TLR2	9.03e-06	2	105	2	18217947
Pubmed	The Staphylococcus aureus lipoprotein SitC colocalizes with Toll-like receptor 2 (TLR2) in murine keratinocytes and elicits intracellular TLR2 accumulation.	NOD2 TLR2	9.03e-06	2	105	2	20679445
Pubmed	Morphine inhibits murine dendritic cell IL-23 production by modulating Toll-like receptor 2 and Nod2 signaling.	NOD2 TLR2	9.03e-06	2	105	2	21245149
Pubmed	Effects of ablation of N- and R-type Ca(2+) channels on pain transmission.	CACNA1B CACNA1E	9.03e-06	2	105	2	12074836
Pubmed	TLR2 and Nod2 mediate resistance or susceptibility to fatal intracellular Ehrlichia infection in murine models of ehrlichiosis.	NOD2 TLR2	9.03e-06	2	105	2	23526993
Pubmed	Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer.	TNC VCAN	9.03e-06	2	105	2	15073129
Pubmed	Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis.	NOD2 TLR2	9.03e-06	2	105	2	17709422
Pubmed	Expression analysis of P/Q-type Ca2+ channel alpha 1A subunit mRNA in olfactory mitral cell in N-type Ca2+ channel alpha 1B subunit gene-deficient mice.	CACNA1A CACNA1B	9.03e-06	2	105	2	15050706
Pubmed	The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn's disease independent of the IL23R genotype.	NOD2 IL23R	9.03e-06	2	105	2	20428899
Pubmed	Retinal astrocytes pretreated with NOD2 and TLR2 ligands activate uveitogenic T cells.	NOD2 TLR2	9.03e-06	2	105	2	22808176
Pubmed	P. gingivalis-Induced TLR2 Interactome Analysis Reveals Association with PARP9.	TLR2 PARP9	9.03e-06	2	105	2	38344758
Pubmed	Molecular characterization of the ankle-link complex in cochlear hair cells and its role in the hair bundle functioning.	ADCY1 ADCY3 USH2A	1.46e-05	16	105	3	17567809
Pubmed	CARD15 and IL23R influences Crohn's disease susceptibility but not disease phenotype in a Brazilian population.	NOD2 IL23R	2.70e-05	3	105	2	18200510
Pubmed	MARCO is required for TLR2- and Nod2-mediated responses to Streptococcus pneumoniae and clearance of pneumococcal colonization in the murine nasopharynx.	NOD2 TLR2	2.70e-05	3	105	2	23197261
Pubmed	NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease.	NOD2 IL23R	2.70e-05	3	105	2	20082483
Pubmed	Toll-like receptor 9, NOD2 and IL23R gene polymorphisms influenced outcome in AML patients transplanted from HLA-identical sibling donors.	NOD2 IL23R	2.70e-05	3	105	2	20622911
Pubmed	Munc13-3 Is Required for the Developmental Localization of Ca2+ Channels to Active Zones and the Nanopositioning of Cav2.1 Near Release Sensors.	CACNA1A CACNA1B	2.70e-05	3	105	2	29466725
Pubmed	Association study between polymorphisms in the CACNA1A, CACNA1C, and CACNA1H genes and drug-resistant epilepsy in the Chinese Han population.	CACNA1A CACNA1H	2.70e-05	3	105	2	26216687
Pubmed	Toll-like receptor 2 deficiency results in impaired antibody responses and septic shock during Borrelia hermsii infection.	NOD2 TLR2	2.70e-05	3	105	2	20696824
Pubmed	Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells.	NOD2 TLR2	2.70e-05	3	105	2	27624090
Pubmed	Calcium-mediated, purinergic stimulation and polarized localization of calcium-sensitive adenylyl cyclase isoforms in human airway epithelia.	ADCY1 ADCY3	2.70e-05	3	105	2	17586501
Pubmed	NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease.	NOD2 IL23R	2.70e-05	3	105	2	20380008
Pubmed	Association of IL23R and ATG16L1 with susceptibility of Crohn's disease in Chinese population.	NOD2 IL23R	2.70e-05	3	105	2	25048429
Pubmed	A novel adenylyl cyclase sequence cloned from the human erythroleukemia cell line.	ADCY1 ADCY3	2.70e-05	3	105	2	8476432
Pubmed	The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in development of Crohn's disease.	NOD2 IL23R	2.70e-05	3	105	2	20537165
Pubmed	Platelet-activating factor receptor and innate immunity: uptake of gram-positive bacterial cell wall into host cells and cell-specific pathophysiology.	NOD2 TLR2	2.70e-05	3	105	2	17056547
Pubmed	Confirmation of three inflammatory bowel disease susceptibility loci in a Chinese cohort.	NOD2 IL23R	2.70e-05	3	105	2	22426692
Pubmed	Pancreatic cancer-derived exosomal microRNA-19a induces β-cell dysfunction by targeting ADCY1 and EPAC2.	RAPGEF4 ADCY1	2.70e-05	3	105	2	34512170
Pubmed	Cooperation between NOD2 and Toll-like receptor 2 ligands in the up-regulation of mouse mFPR2, a G-protein-coupled Abeta42 peptide receptor, in microglial cells.	NOD2 TLR2	2.70e-05	3	105	2	18299458
Pubmed	ATG16L1 Ala197Thr is not associated with susceptibility to Crohn's disease or with phenotype in an Italian population.	NOD2 IL23R	2.70e-05	3	105	2	18166373
Pubmed	NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis.	NOD2 TLR2	2.70e-05	3	105	2	16322770
Pubmed	A role for TLR1, TLR2 and NOD2 in cytokine induction by Bacteroides fragilis.	NOD2 TLR2	2.70e-05	3	105	2	22998942
Pubmed	Molecular moieties masking Ca2+-dependent facilitation of voltage-gated Cav2.2 Ca2+ channels.	CACNA1A CACNA1B	2.70e-05	3	105	2	29208674
Pubmed	Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation.	CACNA1A CACNA1B	2.70e-05	3	105	2	26507659
Pubmed	Association of single nucleotide polymorphisms in CACNA 1A/CACNA 1C/CACNA 1H calcium channel genes with diabetic peripheral neuropathy in Chinese population.	CACNA1A CACNA1H	2.70e-05	3	105	2	29581247
Pubmed	Genetic variations of interleukin-23R (1143A>G) and BPI (A645G), but not of NOD2, are associated with acute graft-versus-host disease after allogeneic transplantation.	NOD2 IL23R	2.70e-05	3	105	2	20541026
Pubmed	Role of ATG16L, NOD2 and IL23R in Crohn's disease pathogenesis.	NOD2 IL23R	2.70e-05	3	105	2	22346247
Pubmed	TLR2 and NODs1 and 2 cooperate in inflammatory responses associated with renal ischemia reperfusion injury.	NOD2 TLR2	2.70e-05	3	105	2	31760144
Pubmed	Replication and meta-analysis of 13,000 cases defines the risk for interleukin-23 receptor and autophagy-related 16-like 1 variants in Crohn's disease.	NOD2 IL23R	2.70e-05	3	105	2	20485703
Pubmed	Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting.	CACNA1A CACNA1B	2.70e-05	3	105	2	24394417
Pubmed	Association of IL23R p.381Gln and ATG16L1 p.197Ala with Crohn disease in the Czech population.	NOD2 IL23R	2.70e-05	3	105	2	19590455
Pubmed	Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin.	FRG2 FRG2B	2.70e-05	3	105	2	11829491
Pubmed	IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease.	NOD2 IL23R	2.70e-05	3	105	2	17894849
Pubmed	Ankyrin-independent membrane protein-binding sites for brain and erythrocyte spectrin.	SPTA1 SPTAN1	2.70e-05	3	105	2	2971657
GeneFamily	Calcium voltage-gated channel subunits	CACNA1A CACNA1B CACNA1E CACNA1F CACNA1H	6.16e-08	26	74	5	253
GeneFamily	EF-hand domain containing\|Spectrins	SPTA1 SPTAN1	3.42e-04	7	74	2	1113
GeneFamily	Adenylate cyclases\|Deafness associated genes	ADCY1 ADCY3	7.28e-04	10	74	2	53
GeneFamily	ATPase phospholipid transporting	ATP9B ATP9A	1.68e-03	15	74	2	1210
Coexpression	GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP	RAPGEF4 SI TPCN1 UTP25 DKC1 WDR13 RNF207	6.15e-06	172	105	7	M2945
Coexpression	KRAS.DF.V1_UP	CBLC RRAD ATP9A KIF3A VCAN TLR2 FADS2	1.22e-05	191	105	7	M2863
Coexpression	ONKEN_UVEAL_MELANOMA_UP	APPBP2 SPTAN1 RAPGEF4 ATP9A ADCY1 ADCY3 WASHC5 RRN3 HERC2 EMC2 NME4 CAMSAP2 ADGRA3	1.67e-05	790	105	13	M12490
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1A CACNA1B SI GRM8 USH2A DNAH8	1.52e-06	150	105	6	0205318a870e091add66ee4305747dda9f51510d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CBLC RRAD GRM8 SCN3A SORCS2 CRYBG1	6.72e-06	194	105	6	46070fbb0ee0eb9e1801c43b73a15707471056dc
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CBLC RRAD GRM8 SCN3A SORCS2 CRYBG1	6.72e-06	194	105	6	abacb6a8d7a9003f2f6c2be0305507f1c1c50347
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	ANXA6 ZNF521 CHRNA1 MRC2 VCAN SORCS2	6.72e-06	194	105	6	55b97095a7a17a312c616703d291738a0f806339
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1B PPFIA3 ADCY1 CADPS SCN3A USH2A	7.12e-06	196	105	6	4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725
ToppCell	(08)_PNEC\|World / shred by cell type and Timepoint	CACNA1A RAPGEF4 ADCY1 CADPS SCN3A CACNA1H	7.12e-06	196	105	6	2ee37155c03cd5009427a4bffe6c80ed2ac6939e
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TNC ANXA6 FAM111A MRC2 VCAN FADS2	7.55e-06	198	105	6	0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TNC ANXA6 FAM111A MRC2 VCAN FADS2	7.77e-06	199	105	6	38ed3bc7daa993d9edcf3e7834597ebb06dd24f8
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CTNNAL1 SPTAN1 RAPGEF4 ZNF521 BIRC6 DOCK6	7.99e-06	200	105	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS-IL1RA-Myeloid-Myeloid_granulocytic-Neutrophils\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPR65 TNC SI VCAN TLR2	8.92e-06	118	105	5	6053e19d040fb394f9c270361af07b0c5a4d47db
ToppCell	LPS-IL1RA-Myeloid-Myeloid_granulocytic\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPR65 TNC SI VCAN TLR2	8.92e-06	118	105	5	811e8521129914eef46785a4227c1860e77d9096
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Hematologic-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTA1 VAT1L NXPE2 FADS2	2.55e-05	72	105	4	5e5eb8c7014396767f3dc7d99cb552edd273bfbd
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Hematologic-erythroblast\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTA1 VAT1L NXPE2 FADS2	2.55e-05	72	105	4	78e158835ec2a37faadf5acdbb62f266cc184e44
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Hematologic\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTA1 VAT1L NXPE2 FADS2	2.55e-05	72	105	4	c4bf1d59845fa54aeb2c8ebeda17bba6641cfb3d
ToppCell	COVID-19-kidney-Technical/muscle\|kidney / Disease (COVID-19 only), tissue and cell type	CACNA1A CST11 FNDC7 CADPS DNAH8	2.67e-05	148	105	5	0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TNC CADPS MRC2 DNAH8 ADGRA3	3.43e-05	156	105	5	bb505f639dbcad2b788db62d6084c2cb4e884bec
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	CACNA1A CACNA1B CADPS USH2A DNAH8	3.76e-05	159	105	5	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	droplet-Limb_Muscle-nan-18m-Myeloid-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F TNC ZNF521 FNDC7 C1QC	4.11e-05	162	105	5	71d7849108a1b59beff40e46000172c45a2f5439
ToppCell	facs-Marrow-KLS-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTA1 SPTLC1 NXPE2 C1QC CAMSAP2	4.11e-05	162	105	5	860ebf2390b4ad86475ad54717cbefcf61cd3b2a
ToppCell	facs-Marrow-KLS-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTA1 SPTLC1 NXPE2 C1QC CAMSAP2	4.11e-05	162	105	5	14e9f8aaba308619eb9da90796c336e76cedac1f
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1A CACNA1B CACNA1E CADPS CACNA1H	4.75e-05	167	105	5	c87ebfa8c3284ad33579190e148c95bcaf670d17
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 SPTA1 SPTLC1 SCN3A USH2A	5.02e-05	169	105	5	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	FLU-Healthy-3\|FLU / Virus stimulation, Condition and Cluster	MTHFSD SPTLC1 ATP9B DPP3 XRCC1	5.61e-05	173	105	5	32b8e5b400885dbeba57a7cb2c18d882664dc285
ToppCell	FLU-Healthy-3\|Healthy / Virus stimulation, Condition and Cluster	MTHFSD SPTLC1 ATP9B DPP3 XRCC1	5.61e-05	173	105	5	26e89ac86922f1cd0100cf4d1cce37e74dd31c88
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPR65 WASHC5 TLR2 C1QC TOP2A	5.61e-05	173	105	5	12c6875f881cb0fbff09d753b53c1cce7a95527f
ToppCell	5'-Adult-LargeIntestine-Epithelial-neuro-epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A ADCY1 CADPS SCN3A CACNA1H	5.77e-05	174	105	5	9f114e61458659005b6d0b4aa30a7a059e7aa5c6
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_E\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	RRAD KYAT1 ZFP1 RNF207 IL23R	6.26e-05	177	105	5	946803293a7955116c80f403e99e4093e798ca3f
ToppCell	COPD-Epithelial-PNEC\|Epithelial / Disease state, Lineage and Cell class	CACNA1B RAPGEF4 CADPS SCN3A CACNA1H	6.60e-05	179	105	5	988d0853c391da1e5004f73f3678047418d3f6d3
ToppCell	facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A ANXA6 ADGB CADPS SCN3A	6.77e-05	180	105	5	9db9899ca42455310e9b63df523fe6c4780abfb7
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1B VAT1L GRM8 CADPS SCN3A	6.77e-05	180	105	5	368ff7fcfd21ad248f96a83a8b191040ba7d8670
ToppCell	RA-07._Pericyte\|RA / Chamber and Cluster_Paper	CACNA1A ADCY1 ADCY3 SCN3A CACNA1H	6.95e-05	181	105	5	8dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-M/X_cells_(MLN/GHRL+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A RAPGEF4 ADCY1 CADPS USH2A	6.95e-05	181	105	5	cb17c904ab86d56dd30cac9b61acbb3b76f84ded
ToppCell	PND10-Immune-Immune_Myeloid-Dendritic-cDC1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPR65 LEMD2 FNDC7 TLR2 TOP2A	7.32e-05	183	105	5	ab38264daddccdf5ffb75ff2210b27423eca6bc0
ToppCell	PND10-Immune-Immune_Myeloid-Dendritic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPR65 LEMD2 FNDC7 TLR2 TOP2A	7.32e-05	183	105	5	e4911601dca2c0ecb448cdb6b222dedfc0c8bf6c
ToppCell	PND10-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPR65 LEMD2 FNDC7 TLR2 TOP2A	7.32e-05	183	105	5	263bfa1d8a7314bc3156c735c403c3bab8ea4dac
ToppCell	PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA1B VAT1L CADPS SCN3A CACNA1H	7.51e-05	184	105	5	3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff
ToppCell	PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA1B VAT1L CADPS SCN3A CACNA1H	7.51e-05	184	105	5	1e2f0cec50475a1cf2973a5082826bbc60fc9a68
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1A CACNA1B RAPGEF4 CADPS SCN3A	7.91e-05	186	105	5	b45cce768e4bf91da194fd9660cab7520dfb15ac
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA1A TNC VAT1L ADCY3 MRC2	8.11e-05	187	105	5	d591a3c216997663ab77710fed0d230ffc37e41a
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA1A TNC VAT1L ADCY3 MRC2	8.11e-05	187	105	5	d1dc8c9a2c2cd10c640257161a75e7730ec5bb41
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA1A TNC VAT1L ADCY3 MRC2	8.11e-05	187	105	5	ac8e092b37e042975e2ee057d3f7c6821e58e8b5
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	CACNA1B CACNA1E VAT1L CADPS SCN3A	8.32e-05	188	105	5	b73e8a40393c3f656e2fcfe395a761b1f985c254
ToppCell	21-Trachea-Epithelial-Neuroendocrine\|Trachea / Age, Tissue, Lineage and Cell class	CACNA1A ADCY1 CADPS SCN3A CACNA1H	8.32e-05	188	105	5	e78d4f7a5d28c77503cb041ff585d13df4c88bd2
ToppCell	LV-14._Fibroblast_III\|World / Chamber and Cluster_Paper	UAP1 ZNF521 ADCY3 VCAN CCDC138	8.53e-05	189	105	5	3922135d1f6fc768d71ba3b465585fead6ea68a8
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-myeloid\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CADPS VCAN TLR2 C1QC CACNA1H	8.53e-05	189	105	5	2aebea7a6c2f83112d7c504b742f2c04b92e459a
ToppCell	RA-14._Fibroblast_III\|RA / Chamber and Cluster_Paper	UAP1 TNC ADCY3 VCAN CCDC138	8.53e-05	189	105	5	46e9a58aacd79db5a02898a8c7244e1884adcfd1
ToppCell	RA-14._Fibroblast_III\|World / Chamber and Cluster_Paper	UAP1 TNC ADCY3 VCAN CCDC138	8.53e-05	189	105	5	b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TNC MRC2 VCAN SORCS2 FADS2	8.74e-05	190	105	5	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	droplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CTNNAL1 TNC ZNF521 SCN3A RNF207	8.96e-05	191	105	5	51cff0594ac7ad8c065c8ea2301f8c149bd062b4
ToppCell	droplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CTNNAL1 TNC ZNF521 SCN3A RNF207	8.96e-05	191	105	5	a55b6f0a7ec1a8852ffca593cfdccd7edea09b7b
ToppCell	droplet-Lung-30m-Endothelial-lymphatic_endothelial\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CTNNAL1 TNC ZNF521 SCN3A RNF207	8.96e-05	191	105	5	38681a1b182d6af5cce85db5431b6eba4b20ad96
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A CACNA1E PPFIA3 ADCY1 RNF207	9.41e-05	193	105	5	be28070c049e7cb68bcd54f582226eb2f5e4bc1c
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_D_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRM8 CPQ VCAN SORCS2 CACNA1H	9.41e-05	193	105	5	6995ee29bf403a71247de92a37dfd851be5acf2e
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1B CACNA1E PPFIA3 CADPS SCN3A	9.41e-05	193	105	5	461919ab422bc9d1fcff7a3a4757c75239041d7e
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1B CACNA1E PPFIA3 CADPS SCN3A	9.41e-05	193	105	5	0dd810ad900d3e586551622b2c1de39d76fd6a7f
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A CACNA1E PPFIA3 ADCY1 RNF207	9.41e-05	193	105	5	0c652ebe22ce5d2927599dd97ef1920547858395
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A CACNA1E PPFIA3 ADCY1 RNF207	9.41e-05	193	105	5	8689a70a33a7c3823dc647d41ac0160e7c3ae396
ToppCell	LV-14._Fibroblast_III\|LV / Chamber and Cluster_Paper	UAP1 ZNF521 ADCY3 VCAN CCDC138	9.64e-05	194	105	5	927c26aea0147f7a4b8fb3f192de4de263f1b978
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TNC ADCY3 SHC3 MRC2 VCAN	9.87e-05	195	105	5	d8ebb94f30d4a655d6b29dd6a3076be2403d2356
ToppCell	11.5-Distal-Epithelial-Neuroendocrine\|Distal / Age, Tissue, Lineage and Cell class	ADCY1 CHRNA1 CADPS SCN3A CACNA1H	9.87e-05	195	105	5	eda6ebe52c48bd6a9044886e75f584f46c2556e7
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TNC ADCY3 SHC3 MRC2 VCAN	1.01e-04	196	105	5	a12dd986df65c36f248cf10815c3b8b6238613b0
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	NELFA GLYATL2 TPCN1 ZNF263 UTP25	1.01e-04	196	105	5	7be50b9156394dea44d7b8b476d4dd516abfafae
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TNC ADCY3 SHC3 MRC2 VCAN	1.01e-04	196	105	5	3e6803587d8566fd08cb8b290be3b6461743d79c
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RAPGEF4 GRM8 ZP1 CACNA1H DOCK6	1.01e-04	196	105	5	73f029d2b276776d6c24356b14c6592c9cb74bd5
ToppCell	erythropoietic\|World / Lineage and Cell class	CTNNAL1 SPTA1 FADS2 NME4 TOP2A	1.04e-04	197	105	5	a52546cebc222050c970e04cec97e4f48ab8fe10
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TNC ADCY3 SHC3 MRC2 VCAN	1.04e-04	197	105	5	6d027119a5f7ca2aac1b10837e43f9a2bb54db85
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TNC ADCY3 SHC3 MRC2 VCAN	1.04e-04	197	105	5	b349f8e96d61a4c296af64711e11fc44459a9413
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TNC ADCY3 SHC3 MRC2 VCAN	1.04e-04	197	105	5	c2e390653d5dee7e731c1840cfdab41987dede9b
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1A CACNA1B RAPGEF4 CADPS SCN3A	1.06e-04	198	105	5	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1A CACNA1B RAPGEF4 CADPS SCN3A	1.06e-04	198	105	5	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GRM8 ADCY3 ZFP1 C1QC CACNA1H	1.06e-04	198	105	5	882710bd6215e299257dd3df234292db9a2823ba
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1A CACNA1B RAPGEF4 CADPS SCN3A	1.06e-04	198	105	5	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1B RAPGEF4 KIF3A CADPS SCN3A	1.06e-04	198	105	5	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TNC FAM111A MRC2 VCAN FADS2	1.09e-04	199	105	5	ba586690f88fd051f449753bfe7603a2cb431782
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TNC FAM111A MRC2 VCAN FADS2	1.09e-04	199	105	5	06a7d874ff7c4616577f6e59d3118717a8c47c00
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	TNC ANXA6 MRC2 VCAN FADS2	1.09e-04	199	105	5	fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCell	LPS_only-Mesenchymal_fibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	TNC ANXA6 MRC2 VCAN FADS2	1.09e-04	199	105	5	211c3a08f2d484ab7a3368006767289088f0d957
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TNC ANXA6 MRC2 VCAN FADS2	1.09e-04	199	105	5	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts\|LPS_only / Treatment groups by lineage, cell group, cell type	TNC ANXA6 MRC2 VCAN FADS2	1.09e-04	199	105	5	1a0add79f4e34078b3475eb11c85a4234bda197c
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CACNA1A RAPGEF4 SHC3 VCAN SCN3A	1.11e-04	200	105	5	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CACNA1A RAPGEF4 SHC3 VCAN SCN3A	1.11e-04	200	105	5	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	CTNNAL1 SPTAN1 RAPGEF4 ZNF521 DOCK6	1.11e-04	200	105	5	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	CACNA1A CACNA1B RAPGEF4 CADPS SCN3A	1.11e-04	200	105	5	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial-Astrocyte\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	TNC ANXA6 TPCN1 FAM111A UTP25	1.11e-04	200	105	5	98a994692440cb4f505b050276f0c8022c814a21
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CACNA1A RAPGEF4 SHC3 VCAN SCN3A	1.11e-04	200	105	5	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CTNNAL1 SPTAN1 RAPGEF4 ZNF521 DOCK6	1.11e-04	200	105	5	a1fa6bae5a688faf488d6925cd3fad725dfa916b
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TNC ANXA6 MRC2 VCAN FADS2	1.11e-04	200	105	5	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	LPS_anti-TNF-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CTNNAL1 SPTAN1 RAPGEF4 ZNF521 DOCK6	1.11e-04	200	105	5	1d105eeda5a2c51f9a4654ffc79b7e2348ad593b
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CACNA1A RAPGEF4 SHC3 VCAN SCN3A	1.11e-04	200	105	5	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	LPS_IL1RA_TNF-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CTNNAL1 SPTAN1 RAPGEF4 ZNF521 DOCK6	1.11e-04	200	105	5	d01cec331be3b03cef80e9536fc531285bcf00f6
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CTNNAL1 SPTAN1 RAPGEF4 ZNF521 DOCK6	1.11e-04	200	105	5	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	LPS_anti-TNF-Endothelial-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CTNNAL1 SPTAN1 RAPGEF4 ZNF521 DOCK6	1.11e-04	200	105	5	60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	TNC ANXA6 TPCN1 FAM111A UTP25	1.11e-04	200	105	5	ef222dc4a205d670172dae74990bdb952ac92e5b
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TNC ANXA6 MRC2 VCAN FADS2	1.11e-04	200	105	5	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CACNA1A RAPGEF4 SHC3 VCAN SCN3A	1.11e-04	200	105	5	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1A TNC BCL2L2 ADCY1 ZFP1	1.11e-04	200	105	5	a372ef3f9e6ff6e3c3376d6e10182977c5067788
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	CTNNAL1 SPTAN1 RAPGEF4 ZNF521 DOCK6	1.11e-04	200	105	5	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CACNA1A RAPGEF4 SHC3 VCAN SCN3A	1.11e-04	200	105	5	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	Control-CD4+_T_activated\|Control / Disease condition and Cell class	RAPGEF4 SHC3 MRC2 PARP9	1.64e-04	116	105	4	e3d1a90a229f5697b2b715574bb96790a435f73b
Drug	AC1L1TJF	CACNA1A CACNA1B CACNA1E CACNA1F ADCY1 ADCY3 NOD2 CACNA1H	6.15e-10	66	103	8	CID000003377
Drug	gallopamil	CACNA1A CACNA1B CACNA1E CACNA1F BIRC6 TPCN1 NOD2 CACNA1H	6.96e-10	67	103	8	CID000001234
Drug	3,4-dihydroquinazoline	CACNA1A CACNA1B CACNA1E CACNA1H	5.88e-09	6	103	4	CID000583065
Drug	bepridil	CACNA1A CACNA1B CACNA1E CACNA1F TNC BIRC6 TPCN1 SCN3A CACNA1H	5.91e-09	126	103	9	CID000002351
Drug	NSC7524	CACNA1A CACNA1B CACNA1E CACNA1F ANXA6 ADCY1 ADCY3 CHRNA1 SCN3A CACNA1H	1.03e-08	182	103	10	CID000005657
Drug	Bay K 8644	CACNA1A CACNA1B CACNA1E CACNA1F ADCY1 ADCY3 TPCN1 NOD2 CACNA1H	2.72e-08	150	103	9	CID000002303
Drug	CAS 298-57-7	CACNA1A CACNA1B CACNA1E CACNA1F TPCN1 NOD2 CACNA1H	4.02e-08	73	103	7	CID000002761
Drug	ethosuximide	CACNA1A CACNA1B CACNA1E CACNA1F CHRNA1 TPCN1 CACNA1H	4.43e-08	74	103	7	CID000003291
Drug	AC1L2VU3	CACNA1A CACNA1B CACNA1E CACNA1H	1.90e-07	12	103	4	CID000129572
Drug	lanthanum	CACNA1A CACNA1B CACNA1E CACNA1F ADCY1 ADCY3 TPCN1 CACNA1H	1.94e-07	136	103	8	CID000023926
Drug	Cinildipine	CACNA1A CACNA1B CACNA1E CACNA1F TPCN1 CACNA1H	2.00e-07	56	103	6	CID000002752
Drug	NSC759576	CACNA1A CACNA1B CACNA1E CACNA1F BIRC6 ADCY1 ADCY3 TPCN1 CACNA1H	2.17e-07	191	103	9	CID000003075
Drug	etorphine	CACNA1A CACNA1B CACNA1E SPTA1 ADCY1 ADCY3	2.75e-07	59	103	6	CID000026721
Drug	nilvadipine	CACNA1A CACNA1B CACNA1E CACNA1F TPCN1 CACNA1H	3.04e-07	60	103	6	CID000004494
Drug	nitrendipine	CACNA1A CACNA1B CACNA1E CACNA1F ADCY1 TPCN1 CACNA1H	3.12e-07	98	103	7	CID000004507
Drug	nimodipine	CACNA1A CACNA1B CACNA1E CACNA1F RAPGEF4 GRM8 TPCN1 CACNA1H	3.18e-07	145	103	8	CID000004497
Drug	nicardipine	CACNA1A CACNA1B CACNA1E CACNA1F CHRNA1 TPCN1 FADS2 CACNA1H	3.18e-07	145	103	8	CID000004473
Drug	isradipine	CACNA1A CACNA1B CACNA1E CACNA1F TPCN1 SCN3A CACNA1H	3.58e-07	100	103	7	CID000003784
Drug	AC 110	CACNA1A CACNA1B CACNA1E	3.58e-07	4	103	3	CID000022860
Drug	CNS 1145	CACNA1A CACNA1B CACNA1E CACNA1F CACNA1H	3.69e-07	33	103	5	CID000190902
Drug	IHC-64	CACNA1A CACNA1B CACNA1E CACNA1F CACNA1H	3.69e-07	33	103	5	CID000162753
Drug	lercanidipine	CACNA1A CACNA1B CACNA1E CACNA1F TPCN1 CACNA1H	4.08e-07	63	103	6	CID000065866
Drug	procaine	CACNA1A CACNA1B CACNA1E CACNA1F CHRNA1 TPCN1 SCN3A CACNA1H	4.80e-07	153	103	8	CID000004914
Drug	butamben	CACNA1A CACNA1B CACNA1E CACNA1H	5.19e-07	15	103	4	CID000002482
Drug	pentasulfane	CACNA1A CACNA1B CACNA1E CACNA1H	6.89e-07	16	103	4	CID000448216
Drug	AC1L2AC7	CACNA1A CACNA1B CACNA1E CACNA1F TPCN1 CACNA1H	7.04e-07	69	103	6	CID000068733
Drug	lamotrigine	CACNA1A CACNA1B CACNA1E CACNA1F TPCN1 SCN3A CACNA1H	9.83e-07	116	103	7	CID000003878
Drug	gabapentin	CACNA1A CACNA1B CACNA1E CACNA1F GRM8 TPCN1 SCN3A CACNA1H	1.02e-06	169	103	8	CID000003446
Drug	1,3-dipropylxanthine	CACNA1A CACNA1B CACNA1E GRM8 ADCY1 ADCY3	1.07e-06	74	103	6	CID000169317
Drug	AC1L1I54	CACNA1A CACNA1B CACNA1E ADCY1 ADCY3	1.13e-06	41	103	5	CID000004426
Drug	nisoldipine	CACNA1A CACNA1B CACNA1E CACNA1F TPCN1 CACNA1H	1.46e-06	78	103	6	CID000004499
Drug	alpha-sialylcholesterol	CACNA1A CACNA1B CACNA1E	1.78e-06	6	103	3	CID000133976
Drug	verapamil	CACNA1A CACNA1B CACNA1E CACNA1F ABCA13 BIRC6 ADCY1 ADCY3 CHRNA1 TPCN1 SCN3A CACNA1H	2.24e-06	490	103	12	CID000002520
Drug	baclofen	CACNA1A CACNA1B CACNA1E CACNA1F GRM8 ADCY1 ADCY3 CACNA1H	2.55e-06	191	103	8	CID000002284
Drug	brimonidine	CACNA1A CACNA1B CACNA1E ADCY1 ADCY3 CHRNA1	2.60e-06	86	103	6	CID000002435
Drug	APMPA	CACNA1A CACNA1B CACNA1E	3.11e-06	7	103	3	CID000512300
Drug	alpha-conotoxin SI	CACNA1A CACNA1B CACNA1E CHRNA1	3.27e-06	23	103	4	CID000163979
Drug	2-amino-4-phosphonobutyric acid	CACNA1A CACNA1B CACNA1E GRM8 ADCY1 ADCY3	3.61e-06	91	103	6	CID000002207
Drug	Dantrolene-13C3	CACNA1A CACNA1B CACNA1E CACNA1F GRM8 TPCN1 CACNA1H	4.37e-06	145	103	7	CID000002951
Drug	manidipine	CACNA1A CACNA1B CACNA1E CACNA1F TPCN1 CACNA1H	4.64e-06	95	103	6	CID000004008
Drug	ethanol	CACNA1B CACNA1E CACNA1F IPO8 SPTA1 SPTAN1 XRCC1 RRAD BIRC6 ADCY1 ADCY3 CHRNA1 NOD2 SCN3A TLR2	5.36e-06	837	103	15	CID000000702
Drug	eniluracil	CACNA1A CACNA1B CACNA1E EXTL3	6.40e-06	27	103	4	CID000043157
Drug	loperamide	CACNA1A CACNA1B CACNA1E CACNA1F TPCN1 CACNA1H	8.29e-06	105	103	6	CID000003954
Drug	IAA-94	CACNA1A CACNA1B CACNA1E CACNA1F CACNA1H	8.36e-06	61	103	5	CID000003667
Drug	N-arachidonoylethanolamine	CACNA1A CACNA1B CACNA1E ADCY1 ADCY3 VCAN FADS2 CACNA1H	8.81e-06	226	103	8	CID000002185
Drug	cobalt-60	CACNA1A CACNA1B CACNA1E CACNA1F CBLC DPP3 ADCY1 ADCY3 TPCN1 CACNA1H	1.11e-05	390	103	10	CID000061492
Drug	felodipine	CACNA1A CACNA1B CACNA1E CACNA1F TPCN1 NOD2 CACNA1H	1.19e-05	169	103	7	CID000003333
Drug	halothane	CACNA1A CACNA1B CACNA1E CACNA1F ADCY1 ADCY3 CHRNA1 TPCN1 CACNA1H	1.30e-05	314	103	9	CID000003562
Drug	riluzole	CACNA1A CACNA1B CACNA1E CACNA1F GRM8 SCN3A CACNA1H	1.44e-05	174	103	7	CID000005070
Drug	leys	CACNA1A CACNA1B CACNA1E	1.44e-05	11	103	3	CID000484683
Drug	GTP[S]	CACNA1A CACNA1B CACNA1E GPR65 RAPGEF4 GRM8 ADCY1 ADCY3 TPCN1 SCN3A CACNA1H NME4	1.49e-05	591	103	12	CID000001764
Drug	DPCPX	CACNA1A CACNA1B CACNA1E GRM8 ADCY1 ADCY3	1.54e-05	117	103	6	CID000001329
Drug	papaverine	CACNA1A CACNA1B CACNA1E CACNA1F ADCY1 ADCY3 CACNA1H	1.55e-05	176	103	7	CID000004680
Drug	Barium	CACNA1A CACNA1B CACNA1E CACNA1F CACNA1H	1.89e-05	72	103	5	ctd:D001464
Drug	nifedipine	CACNA1A CACNA1B CACNA1E CACNA1F GRM8 BIRC6 TPCN1 NOD2 FADS2 CACNA1H	1.90e-05	415	103	10	CID000004485
Drug	D-isoglutamine	NOD2 VCAN TLR2	1.92e-05	12	103	3	CID000164697
Drug	aristolactam AII	CACNA1B CACNA1E	2.03e-05	2	103	2	CID000148657
Drug	alkosin	CACNA1B CACNA1E	2.03e-05	2	103	2	CID005488638
Drug	norcepharadione B	CACNA1B CACNA1E	2.03e-05	2	103	2	CID000189168
Drug	piperolactam A	CACNA1B CACNA1E	2.03e-05	2	103	2	CID003081016
Drug	pimozide	CACNA1A CACNA1B CACNA1E CACNA1F TPCN1 CACNA1H	2.46e-05	127	103	6	CID000016362
Drug	3,4-diaminopyridine	CACNA1A CACNA1B CACNA1E CHRNA1	2.59e-05	38	103	4	CID000005918
Drug	dihydropyridine	CACNA1A CACNA1B CACNA1E CACNA1F TPCN1 NOD2 CACNA1H	2.81e-05	193	103	7	CID000104822
Drug	E 14	CACNA1A CACNA1B TNC VCAN	2.88e-05	39	103	4	CID000122591
Drug	N-cyclopentyl-N-cyclobutylformamide	CACNA1A CACNA1B CACNA1E CACNA1F CACNA1H	2.97e-05	79	103	5	CID005287890
Drug	Tyr-D-Ala-Gly-N-methyl-Phe-Gly-ol	CACNA1B CACNA1E ADCY1 ADCY3 NME4	3.16e-05	80	103	5	CID004488326
Drug	(-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A	DCAF1 CACNA1A IPO8 BCL2L2 EXTL3 BORCS8 CACNA1H	3.42e-05	199	103	7	6458_DN
Drug	gadolinium	CACNA1A CACNA1B CACNA1E CACNA1F CPQ CACNA1H USH2A	3.42e-05	199	103	7	CID000023982
Drug	aspirin, USP; Down 200; 100uM; HL60; HT_HG-U133A	CACNA1A AEN GPR65 GRM8 ADGB DOCK6 CAMSAP2	3.53e-05	200	103	7	2664_DN
Drug	Fk 888	CACNA1A CACNA1B CACNA1E EXTL3	3.87e-05	42	103	4	CID000107967
Drug	Verapamil	CACNA1A CACNA1B CACNA1F	4.82e-05	16	103	3	DB00661
Drug	muscarine	CACNA1B ANXA6 ADCY1 ADCY3 CHRNA1 NOD2	4.98e-05	144	103	6	CID000009308
Drug	phenytoin	CACNA1A CACNA1B CACNA1E CACNA1F TPCN1 SCN3A CACNA1H	6.27e-05	219	103	7	CID000001775
Drug	KW-3049	CACNA1A CACNA1B CACNA1F CACNA1H	7.75e-05	50	103	4	CID000002324
Drug	isotetrandrine	CACNA1A CACNA1B CACNA1E CACNA1F CACNA1H	7.96e-05	97	103	5	CID000005422
Drug	pranidipine	CACNA1A CACNA1B CACNA1E	8.27e-05	19	103	3	CID006436048
Drug	N6-Me-dAdo	CACNA1A CACNA1B CACNA1E	8.27e-05	19	103	3	CID000168948
Drug	calmidazolium chloride	CACNA1A CACNA1B CACNA1E TNC ADCY1 ADCY3	8.94e-05	160	103	6	CID000002531
Drug	glutamate	CACNA1A CACNA1B CACNA1E CACNA1F TNC GRM8 ADCY1 ADCY3 CHRNA1 KYAT1 NOD2 MDN1 CPQ CACNA1H	1.09e-04	962	103	14	CID000000611
Drug	nefiracetam	CACNA1A CACNA1B CACNA1E CHRNA1	1.21e-04	56	103	4	CID000071157
Drug	AC1L1F6H	CACNA1A CACNA1B CACNA1E ADCY1 ADCY3	1.21e-04	106	103	5	CID000003104
Drug	AC1L1KS5	CACNA1A CACNA1B CACNA1E CACNA1F GRM8 ADCY1 ADCY3 CACNA1H	1.40e-04	334	103	8	CID000005631
Drug	LY320135	CACNA1A CACNA1B CACNA1E	1.49e-04	23	103	3	CID005311257
Drug	ABT-418	CACNA1B CACNA1E CHRNA1	1.49e-04	23	103	3	CID000119380
Drug	propranolol	CACNA1A CACNA1B CACNA1E CACNA1F BIRC6 ADCY1 ADCY3 CHRNA1 CACNA1H	1.58e-04	434	103	9	CID000004946
Drug	AC1L1KC5	CACNA1A CACNA1B CACNA1E CACNA1F RAPGEF4 GRM8 ADCY3 CHRNA1 TPCN1 CACNA1H	1.72e-04	541	103	10	CID000005428
Drug	amsonine	CACNA1A CACNA1B CACNA1E ADCY1 ADCY3 CHRNA1	1.75e-04	181	103	6	CID000002866
Drug	AC1NBU2S	CACNA1A CACNA1B CACNA1E CACNA1F CACNA1H	1.93e-04	117	103	5	CID004473765
Drug	almagel	CACNA1B CACNA1E	2.01e-04	5	103	2	CID003080942
Drug	S 8510	CACNA1A CACNA1B	2.01e-04	5	103	2	CID005488383
Drug	mibefradil	CACNA1A CACNA1B TPCN1 CACNA1H	2.04e-04	64	103	4	CID000060662
Drug	NiCl2	CACNA1A CACNA1B CACNA1E NOD2 CACNA1H	2.09e-04	119	103	5	CID000024385
Drug	caffeine	CACNA1A CACNA1B CACNA1E CACNA1F GRM8 ADCY1 ADCY3 CHRNA1 TPCN1 CACNA1H	2.34e-04	562	103	10	CID000002519
Drug	mAHP	CACNA1A CACNA1B CACNA1E	2.43e-04	27	103	3	CID000220531
Drug	Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A	SPTAN1 EXTL3 GRM8 CPQ VCAN TLR2	2.48e-04	193	103	6	6646_DN
Drug	Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	IPO8 SPTAN1 EXTL3 ADCY3 UTP25 RRN3	2.55e-04	194	103	6	3867_DN
Drug	Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; HL60; HT_HG-U133A	AEN ATP9B GRM8 MRC2 CAMSAP2 SENP5	2.55e-04	194	103	6	3035_DN
Drug	DCG-IV	CACNA1A CACNA1B CACNA1E GRM8	2.58e-04	68	103	4	CID000115114
Drug	AC1NSKJI	BIRC6 ADCY1 ADCY3 CHRNA1	2.58e-04	68	103	4	CID005311391
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A	SPTAN1 RO60 BCL2L2 EXTL3 ADCY3 SENP5	2.62e-04	195	103	6	1665_DN
Disease	familial hemiplegic migraine 1 (implicated_via_orthology)	CACNA1A CACNA1B CACNA1E	3.78e-08	3	100	3	DOID:0111181 (implicated_via_orthology)
Disease	migraine (implicated_via_orthology)	CACNA1A CACNA1B CACNA1E	1.51e-07	4	100	3	DOID:6364 (implicated_via_orthology)
Disease	hereditary ataxia (implicated_via_orthology)	CACNA1A CACNA1B CACNA1E	1.31e-06	7	100	3	DOID:0050951 (implicated_via_orthology)
Disease	Bipolar Disorder	CACNA1A CACNA1B ABCA13 PHETA1 ADCY3 NOD2 TLR2 SORCS2 FADS2 DNAH8	5.24e-06	477	100	10	C0005586
Disease	Ulcerative Colitis	GPR65 NOD2 HERC2 IL23R	6.34e-05	63	100	4	C0009324
Disease	meningococcal meningitis (is_implicated_in)	NOD2 TLR2	6.79e-05	4	100	2	DOID:0080176 (is_implicated_in)
Disease	rhinitis (is_implicated_in)	NOD2 TLR2 IL23R	1.43e-04	30	100	3	DOID:4483 (is_implicated_in)
Disease	1-stearoyl-2-dihomo-linolenoyl-GPC (18:0/20:3n3 or 6) measurement	RRN3 FADS2	1.69e-04	6	100	2	EFO_0800434
Disease	Akinetic Petit Mal	CACNA1A CACNA1H	2.36e-04	7	100	2	C0001890
Disease	Epilepsy, Absence, Atypical	CACNA1A CACNA1H	2.36e-04	7	100	2	C0751124
Disease	Absence Seizure Disorder	CACNA1A CACNA1H	2.36e-04	7	100	2	C4553705
Disease	Juvenile Absence Epilepsy	CACNA1A CACNA1H	2.36e-04	7	100	2	C4317339
Disease	Childhood Absence Epilepsy	CACNA1A CACNA1H	2.36e-04	7	100	2	C4281785
Disease	Epilepsy, Minor	CACNA1A CACNA1H	2.36e-04	7	100	2	C4552765
Disease	Absence Epilepsy	CACNA1A CACNA1H	2.36e-04	7	100	2	C0014553
Disease	epilepsy (implicated_via_orthology)	CACNA1A CACNA1B CACNA1E GRM8 SCN3A	2.39e-04	163	100	5	DOID:1826 (implicated_via_orthology)
Disease	Behcet's disease (is_implicated_in)	NOD2 TLR2 IL23R	2.49e-04	36	100	3	DOID:13241 (is_implicated_in)
Disease	rheumatoid arthritis, Crohn's disease	NOD2 FADS2 IL23R	2.92e-04	38	100	3	EFO_0000384, EFO_0000685
Disease	Leprosy	TLR2 IL23R	3.14e-04	8	100	2	C0023343
Disease	leprosy (is_implicated_in)	NOD2 TLR2	3.14e-04	8	100	2	DOID:1024 (is_implicated_in)
Disease	level of Phosphatidylcholine (O-18:2_16:0) in blood serum	SORCS2 FADS2	5.03e-04	10	100	2	OBA_2045132
Disease	multiple sclerosis (is_marker_for)	CACNA1B BCL2L2 GRM8	6.21e-04	49	100	3	DOID:2377 (is_marker_for)
Disease	level of Phosphatidylinositol (16:0_18:1) in blood serum	RRN3 FADS2	7.34e-04	12	100	2	OBA_2045152
Disease	phosphatidylcholine 40:7 measurement	RRN3 FADS2	8.66e-04	13	100	2	EFO_0021477
Disease	level of Phosphatidylinositol (18:1_18:1) in blood serum	FADS2 DOCK6	8.66e-04	13	100	2	OBA_2045159
Disease	allergic rhinitis (is_marker_for)	NOD2 TLR2	1.50e-03	17	100	2	DOID:4481 (is_marker_for)
Disease	laryngeal squamous cell carcinoma	VCAN FADS2	1.50e-03	17	100	2	EFO_0006352
Disease	IGF-1 measurement, IGFBP-3 measurement	ADCY1 SORCS2	1.50e-03	17	100	2	EFO_0004626, EFO_0004627
Disease	level of Phosphatidylinositol (18:0_18:1) in blood serum	FADS2 DOCK6	1.68e-03	18	100	2	OBA_2045155
Disease	receptive language perception	IPO8 KIF3A	1.87e-03	19	100	2	EFO_0005686
Disease	phosphatidylcholine 34:2 measurement	CACNA1A FADS2	2.08e-03	20	100	2	EFO_0010376
Disease	ulcerative colitis, Crohn's disease	NOD2 IL23R	2.08e-03	20	100	2	EFO_0000384, EFO_0000729
Disease	alpha-tocopherol measurement	SCN3A USH2A	2.08e-03	20	100	2	EFO_0007898
Disease	level of Phosphatidylinositol (18:0_18:2) in blood serum	FADS2 DOCK6	2.29e-03	21	100	2	OBA_2045156
Disease	free cholesterol in large HDL measurement	RRN3 FADS2 DOCK6	2.48e-03	79	100	3	EFO_0022157
Disease	nucleus accumbens volume	BIRC6 USH2A	2.51e-03	22	100	2	EFO_0006931
Disease	cholesterol in large HDL measurement	RRN3 FADS2 DOCK6	2.57e-03	80	100	3	EFO_0021900
Disease	sphingomyelin measurement	SPTLC1 RRN3 FADS2 DOCK6 USH2A	2.60e-03	278	100	5	EFO_0010118
Disease	level of Phosphatidylinositol (18:0_20:4) in blood serum	FADS2 DOCK6	2.75e-03	23	100	2	OBA_2045158
Disease	triacylglycerol 56:4 measurement	IPO8 FADS2	2.99e-03	24	100	2	EFO_0010431
Disease	arachidonic acid measurement	CACNA1A FADS2	3.24e-03	25	100	2	EFO_0006808
Disease	pallidum volume change measurement, age at assessment	GRM8 SORCS2	3.24e-03	25	100	2	EFO_0008007, EFO_0021494

Protein segments in the cluster

Peptide	Gene	Start	Entry
WMVLGAISLLYNQEE	UMODL1-AS1	111	Q8N2C9
TAMELYRLVEVQWEQ	AEN	261	Q8WTP8
FQILTGEDWNEVMYD	CACNA1A	661	O00555
AAAVWAVVSYVVADM	CPQ	451	Q9Y646
IMAQCEEWIADIQQY	BIRC6	4766	Q9NR09
EEQMFVNRVGHDYQW	VCAN	3211	P13611
IHVSEEQLQLYWAMD	CBLC	331	Q9ULV8
FQILTGEDWNEVMYN	CACNA1E	651	Q15878
VWAVLEMNLEQYAVS	ADGB	946	Q8N7X0
QDMQVLWYQDGRIVE	ADGRA3	271	Q8IWK6
NMSVLIPEEYLDWQE	ABCA13	566	Q86UQ4
QVQEWMVAYLETQLA	BCL2L2	121	Q92843
MAAVELEWIPETLYN	APPBP2	1	Q92624
EVMAVENYAKDSLQW	CST11	36	Q9H112
VFQILTGEDWNAVMY	CACNA1B	656	Q00975
AQVAYQMWELSAVAR	ANXA6	336	P08133
GFNVEEMYEAHAWIQ	PARP9	521	Q8IXQ6
EEASLMVYDIWEQDG	RRAD	136	P55042
ESNNAAAEWKYVAMV	CHRNA1	411	P02708
QILTGEDWNVVMYDG	CACNA1F	706	O60840
SDDEQDRILWVQAMY	CADPS	606	Q9ULU8
NHIVMEIDQEAYRDW	FADS2	341	O95864
NVLSDVVNYTLWLME	DCAF1	436	Q9Y4B6
NTYWIDEPDVLVMAV	MDN1	2506	Q9NU22
LVDTVFEMNYATGQW	NELFA	501	Q9H3P2
VVQDHYVDWEQDMER	LEMD2	421	Q8NC56
YAWAVQNIRNVLMDA	HERC2	1736	O95714
SDSILVQWEAVYMAI	FNDC7	126	Q5VTL7
ISWEQILAYGDMNHE	PPFIA3	941	O75145
VAMSPIVQYNDWLEE	ATP9B	661	O43861
IWAMDAPQEVYNDIV	LIPF	376	P07098
WLGANVMLEYDIDEA	VBP1	126	P61758
SQYEVRGAAQVMWFE	PCNX3	1121	Q9H6A9
SETVHQLEEVLMVWY	DNAH8	136	Q96JB1
MQLEEQQRLVYWLEV	KIF7	1126	Q2M1P5
AVLSILDEMENVFVW	MRC2	1301	Q9UBG0
EDVIYVNWLNMVRAG	DPP3	536	Q9NY33
DVVMAGIVQYNDWLE	ATP9A	571	O75110
QEMIENYVHWNEDIG	KIF3A	601	Q9Y496
YQAQAMVDIVTALGW	GRM8	201	O00222
EVWLAVNDYYDMVGI	C1QC	216	P02747
AMSEAVYQDLAQVWA	FRG2B	181	Q96QU4
RAMSEAVYQDLAQVW	FRG2C	181	A6NGY1
AMSEAVYQDLAQVWA	FRG2	181	Q64ET8
YDVWSNDVTLANVME	ADCY1	416	Q08828
NGQVYELLTVFMDWI	CCDC138	351	Q96M89
DAQVRAAVEMYIEDW	DOCK6	106	Q96HP0
WEDQENEIVQYGRNM	CTNNAL1	586	Q9UBT7
YLVAETREDMNEWVQ	GAB4	131	Q2WGN9
PWYEEVFVNQQDVEM	FAM111A	591	Q96PZ2
PYQDMLQWNEAALVV	EXTL3	471	O43909
MNQVTIQWDAVIALY	IL23R	1	Q5VWK5
ADMQRWEEQSQGAIY	BORCS8	51	Q96FH0
YDIWGNTVNVASRME	ADCY3	1061	O60266
DIWIIYEQVMIAALD	EMC2	51	Q15006
QVMEDVGADDQIWIY	CRYBG1	1616	Q9Y4K1
LTQEDWNVVLYNGMA	CACNA1H	971	O95180
VTMHDVLDAQWLYDN	DKC1	261	O60832
DIEDAVMYWINKVNE	CAMSAP2	176	Q08AD1
MWQLLGILYEVFQQD	IPO8	671	O15397
QEMQDITWEVVYLDG	NMRK1	156	Q9NWW6
PIYQVWEDMSAEELQ	RRN3	576	Q9NYV6
VMYSGEETNLWVLID	USH2A	2386	O75445
DQADIYLMQNWEHVL	UTP25	481	Q68CQ4
EGMRVVFQEIWEEAY	RNF207	486	Q6ZRF8
VLQWAAMYGDLLQED	RAPGEF4	581	Q8WZA2
YVLAAESQDAMEGWV	PHETA1	91	Q8N4B1
LNVGIIDAWDMTIAY	NXPE2	521	Q96DL1
VVAMVWEGYNVVRAS	NME4	106	O00746
HDVVCITDEVYQWMV	KYAT1	206	Q16773
ESQVFVAVQEWYQMD	SORCS2	396	Q96PQ0
LEELQAETWYQGEMS	SHC3	491	Q92529
EEPEDMWHTYNLVQV	PELO	21	Q9BRX2
MAAVWQQVLAVDARY	WDR13	1	Q9H1Z4
NWLDFSVIVMAYVTE	SCN3A	191	Q9NY46
EVQYDGLWIDMNEVS	SI	496	P14410
IANSQDGYVWQVTDM	RO60	16	P10155
QAADYNWVVSLMVSV	OR9A4	266	Q8NGU2
EQWVLVEMVQALYEA	SPTLC1	6	O15269
LENYMNLASVEWEIQ	ZNF561	71	Q8N587
VMLENYSNLLSVEVW	ZFP1	36	Q6P2D0
NWLNDQVINMYGELI	SENP5	581	Q96HI0
DNWVISIYMGITVNL	WASHC5	286	Q12768
SIYMGITVNLVDAWE	WASHC5	291	Q12768
TMQVAGDQLIYENWL	ZP1	336	P60852
IYTENVLEVWADVGM	NOD2	251	Q9HC29
EYLAPWANQIDMALV	RPEL1	126	Q2QD12
MEAEVWEAEGYNLVL	WDR97	1	A6NE52
LVQYLRECEDVMDWI	SPTAN1	151	Q13813
QMVFYNEWDIQVHVA	ZNF521	1201	Q96K83
QDIREQIWGYMESQN	MTHFSD	11	Q2M296
LAWDNEMRVTEYLVV	TNC	641	P24821
LLAYEAGDMLEWIQE	SPTA1	1086	P02549
VMAFVNYNAWAEVVC	VAT1L	126	Q9HCJ6
NAVMLWEDETVVEYC	GPR65	146	Q8IYL9
VEDMEQRGIWSIHVY	UAP1	236	Q16222
FELTVVNNWYIIMEG	TPCN1	641	Q9ULQ1
IGSVELVTQQMWVYD	TOP2A	51	P11388
LVTQQMWVYDEDVGI	TOP2A	56	P11388
QGEVDWLQQYDMERE	USP37	791	Q86T82
YMSDRVQFVITAQEW	XRCC1	576	P18887
MQNVSWYERNEVEIV	TMC2	461	Q8TDI7
EYLAPWANQIDMALV	RPE	126	Q96AT9
DVMLENYKNLVAVDW	ZNF559	41	Q9BR84
DAYWVENLMVQELEN	TLR2	651	O60603
DVAMYISQEEWGHQD	ZNF263	221	O14978
NMEVLVDAWPDYQIV	GLYATL2	41	Q8WU03